Poseida Therapeutics, Inc.
NASDAQ:PSTX
3.28 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2017 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 71.748 | 25.973 | 28.142 | 24.995 | 9.352 | 20.013 | 10.343 | 9.921 | 116.306 | 2.7 | 1.435 | 0.031 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 1.349 | 1.38 | 4.176 | 1.444 | 1.408 | 1.324 | 1.355 | 1.35 | 1.26 | 1.207 | 0.031 | 1.169 | 1.128 | 1.072 | 103.52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 71.748 | 24.624 | 26.762 | 20.819 | 7.908 | 18.605 | 9.019 | 8.566 | 114.956 | 1.44 | 0.228 | 0 | -1.169 | -1.128 | -1.072 | -103.52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | 0.948 | 0.951 | 0.833 | 0.846 | 0.93 | 0.872 | 0.863 | 0.988 | 0.533 | 0.159 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 41.914 | 44.198 | 41.541 | 42.046 | 37.482 | 39.192 | 38.052 | 33.904 | 35.137 | 35.008 | 48.85 | 0.039 | 32.524 | 36.008 | 29.095 | 0.028 | 27.016 | 25.21 | 23.414 | 19.204 | 15.696 | 16.881 | 8.613 | 9.753 | 4.354 |
| General & Administrative Expenses
| 10.092 | 12.182 | 9.798 | 8.86 | 8.092 | 8.676 | 11.807 | 9.368 | 9.389 | 9.237 | 9.546 | 0.01 | 9.066 | 8.871 | 8.369 | 0.007 | 6.458 | 4.236 | 4.854 | 4.008 | 4.007 | 4.042 | 6.399 | 2.397 | 1.595 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.092 | 12.182 | 9.798 | 8.86 | 8.092 | 8.676 | 11.807 | 9.368 | 9.389 | 9.237 | 9.546 | 0.01 | 9.066 | 8.871 | 8.369 | 0.007 | 6.458 | 4.236 | 4.854 | 4.008 | 4.007 | 4.042 | 6.399 | 2.397 | 1.595 |
| Other Expenses
| 0 | 2.644 | 2.556 | -12.024 | 6.787 | 2.54 | 2.697 | 2.17 | 0.656 | 0.052 | -0.019 | 0.02 | 0.003 | 0.017 | -0.012 | 0 | -0.092 | -0.09 | 0.398 | 0.519 | 0.744 | 0.619 | 0.676 | 0 | 0 |
| Operating Expenses
| 52.006 | 56.38 | 51.339 | 50.906 | 45.574 | 47.868 | 49.859 | 43.272 | 44.526 | 44.245 | 58.396 | 0.049 | 41.59 | 44.879 | 37.464 | 0.035 | 33.474 | 29.446 | 28.268 | 23.212 | 19.703 | 20.923 | 15.012 | 12.255 | 4.8 |
| Operating Income
| 19.742 | -31.756 | -24.577 | -25.911 | -36.222 | -27.855 | -39.516 | -33.221 | 71.78 | -41.545 | -56.961 | -0.017 | -41.59 | -44.879 | -37.464 | -0.035 | -33.474 | -29.446 | -28.268 | -23.212 | -20.763 | -28.343 | -13.215 | -12.15 | -5.949 |
| Operating Income Ratio
| 0.275 | -1.223 | -0.873 | -1.037 | -3.873 | -1.392 | -3.821 | -3.349 | 0.617 | -15.387 | -39.694 | -0.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.536 | 0.385 | 0.303 | 0.56 | 4.551 | 0.399 | 0.669 | 0.195 | -1.119 | -1.491 | -1.096 | 18.947 | -0.834 | -0.826 | -0.85 | -0.788 | -0.94 | -0.982 | -0.516 | -0.401 | -1.251 | -7.704 | 1.678 | -0.734 | 0.819 |
| Income Before Tax
| 20.278 | -31.371 | -24.274 | -25.349 | -31.671 | -27.456 | -38.847 | -33.026 | 70.661 | -43.036 | -58.057 | 0.001 | -42.424 | -45.705 | -38.314 | -0.036 | -34.414 | -30.428 | -28.784 | -23.613 | -20.954 | -28.627 | -13.334 | -12.884 | -5.13 |
| Income Before Tax Ratio
| 0.283 | -1.208 | -0.863 | -1.014 | -3.387 | -1.372 | -3.756 | -3.329 | 0.608 | -15.939 | -40.458 | 0.047 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.043 | 0 | 1.337 | -6.04 | -0.107 | 4.681 | 1.359 | 0.292 | 0.252 | 1.491 | 1.096 | -17.602 | 0.84 | 0.86 | 0.826 | -1.039 | 0.756 | 0.802 | 1.312 | 1.439 | 1.679 | 1.522 | 1.471 | 0.006 | 0.339 |
| Net Income
| 20.235 | -31.371 | -24.274 | -23.99 | -31.778 | -27.456 | -40.206 | -33.318 | 70.409 | -44.527 | -59.153 | 0.001 | -42.424 | -45.705 | -38.314 | -0.036 | -34.414 | -30.428 | -28.784 | -23.613 | -20.954 | -28.627 | -13.334 | -12.89 | -4.791 |
| Net Income Ratio
| 0.282 | -1.208 | -0.863 | -0.96 | -3.398 | -1.372 | -3.887 | -3.358 | 0.605 | -16.491 | -41.222 | 0.047 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.21 | -0.32 | -0.25 | -0.27 | -0.35 | -0.32 | -0.47 | -0.39 | 0.92 | -0.71 | -0.95 | 0.02 | -0.68 | -0.74 | -0.62 | -0.001 | -0.63 | -0.53 | -0.5 | -0.59 | -0.53 | -0.72 | -0.34 | -1.05 | -0.41 |
| EPS Diluted
| 0.21 | -0.32 | -0.25 | -0.27 | -0.35 | -0.32 | -0.47 | -0.39 | 0.92 | -0.71 | -0.95 | 0.02 | -0.68 | -0.74 | -0.62 | -0.001 | -0.63 | -0.53 | -0.5 | -0.59 | -0.53 | -0.72 | -0.34 | -1.05 | -0.41 |
| EBITDA
| 19.742 | -27.763 | -20.641 | -21.644 | -27.991 | -23.907 | -35.495 | -29.696 | 73.786 | -40.233 | -55.773 | 3.492 | -40.418 | -43.734 | -36.404 | -34.256 | -32.879 | -29.093 | -27.454 | -22.307 | -19.672 | -27.465 | -12.338 | -11.997 | -5.775 |
| EBITDA Ratio
| 0.275 | -1.171 | -0.824 | -1.848 | -3.873 | -1.195 | -3.56 | -3.13 | 0.634 | -14.901 | -38.866 | 0.074 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |